← Leaderboards
Sarah J. Nelson
University Of California San Francisco
$26,058,232
Attributed
$27,428,820
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$38,196,153 · 19
By mechanism
P01$18,264,516 · 5
R01$10,905,742 · 5
P50$3,127,502 · 2
S10$2,799,500 · 2
P41$1,687,955 · 2
R21$1,030,748 · 2
Top collaborators
- Susan M Chang5 shared
- Sabrina Miriam Ronen5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Nicholas M Barbaro$8,817,398
- Tracy Richmond McKnight$3,226,051
- John V Fahy$35,378,030
- Margaret R. Wrensch$18,687,663
- Michael A. Matthay$26,142,041
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImageMetabolicMagnetic Resonance ImagingCholineSamplingTumorResponseLesionTissue SampleBaseMolecularBiologicalTissuesNewly DiagnosedIn VivoMonitorRecurrenceImaging ModalityPhysiologicalCharacteristicsTreatment EffectOperative Surgical ProceduresTechnologyClinical Trials
Grant awards (77)
TR&D3: Open-Source Tools for Processing Hyperpolarized MR Data$277,481
P41 · FY2020 · EB · contact PI
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of Glioma$427,804
P01 · FY2019 · CA · contact PI
TR&D3: Open-Source Tools for Processing Hyperpolarized MR Data$277,481
P41 · FY2019 · EB · contact PI
Project 2: Monitoring metabolism in GBM using hyperpolarized C-13 imaging and H-1 MRSI$366,649
P50 · FY2018 · CA · contact PI
Cancer Imaging Research Shared Resource$357,341
P30 · FY2018 · CA · contact PI
TR&D3: Open-Source Tools for Processing Hyperpolarized MR Data$277,481
P41 · FY2018 · EB · contact PI
Cancer Imaging Research Shared Resource$10,744
P30 · FY2018 · CA · contact PI
Cancer Imaging Research Shared Resource$8,605
P30 · FY2018 · CA · contact PI
Cancer Imaging Research Shared Resource$3,500
P30 · FY2018 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,175,899
P01 · FY2017 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis$583,998
P01 · FY2017 · CA · contact PI
TR&D3: Open-Source Tools for Processing Hyperpolarized MR Data$277,479
P41 · FY2017 · EB · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,170,035
P01 · FY2016 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis$565,012
P01 · FY2016 · CA · contact PI
MR Metabolic Markers for Evaluation of Patients with Recurrent Glioma$351,706
R01 · FY2016 · CA · contact PI
TR&D3: Open-Source Tools for Processing Hyperpolarized MR Data$277,961
P41 · FY2016 · EB · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,180,843
P01 · FY2015 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis$603,717
P01 · FY2015 · CA · contact PI
MR Metabolic Imaging of Response to Targeted Therapies in GBM$486,781
R01 · FY2015 · CA
MR Metabolic Markers for Evaluation of Patients with Recurrent Glioma$351,788
R01 · FY2015 · CA · contact PI
Impact of molecular phenotype on glioma metabolism and growth$298,868
R01 · FY2015 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,101,713
P01 · FY2014 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis$592,568
P01 · FY2014 · CA · contact PI
MR Metabolic Imaging of Response to Targeted Therapies in GBM$476,562
R01 · FY2014 · CA
MR Metabolic Markers for Evaluation of Patients with Recurrent Glioma$336,443
R01 · FY2014 · CA · contact PI
Impact of molecular phenotype on glioma metabolism and growth$290,580
R01 · FY2014 · CA · contact PI
Imaging and Tissue Correlates to Optimize Management of Glioblastoma$2,138,843
P01 · FY2013 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis$579,566
P01 · FY2013 · CA · contact PI
MR Metabolic Imaging of Response to Targeted Therapies in GBM$550,983
R01 · FY2013 · CA
MR Metabolic Markers for Evaluation of Patients with Recurrent Glioma$344,986
R01 · FY2013 · CA · contact PI
RESPONSE TO THERAPY FOR PATIENTS WITH GLIOMA USING HYPERPOLARIZED C-13 PYRUVATE$306,229
R21 · FY2013 · CA · contact PI
MR Metabolic Imaging of Response to Targeted Therapies in GBM$586,859
R01 · FY2012 · CA
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM$344,574
R01 · FY2012 · CA · contact PI
RESPONSE TO THERAPY FOR PATIENTS WITH GLIOMA USING HYPERPOLARIZED C-13 PYRUVATE$324,738
R21 · FY2012 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$59,989
P50 · FY2012 · CA · contact PI
MR Metabolic Imaging of Response to Targeted Therapies in GBM$639,992
R01 · FY2011 · CA
IMaging and Tissue Correlate Core$519,387
P01 · FY2011 · CA · contact PI
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM$382,605
R01 · FY2011 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$310,146
P50 · FY2011 · CA · contact PI
Open-Source Tools for Processing Hyperpolarized MR Data$300,072
P41 · FY2011 · EB · contact PI
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag$288,637
P01 · FY2011 · CA · contact PI
3T MR Scanner for Translational Research using MRI and MRSI$2,299,500
S10 · FY2010 · RR · contact PI
IMaging and Tissue Correlate Core$544,541
P01 · FY2010 · CA · contact PI
Upgrading a 7T Scanner to Study Cancer, Neurological and Musculoskeletal Diseases$500,000
S10 · FY2010 · RR · contact PI
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM$468,329
R01 · FY2010 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$332,085
P50 · FY2010 · CA · contact PI
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag$299,402
P01 · FY2010 · CA · contact PI
IMaging and Tissue Correlate Core$525,036
P01 · FY2009 · CA · contact PI
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM$464,916
R01 · FY2009 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$325,201
P50 · FY2009 · CA · contact PI
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag$288,378
P01 · FY2009 · CA · contact PI
IMaging and Tissue Correlate Core$514,411
P01 · FY2008 · CA · contact PI
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM$398,516
R01 · FY2008 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$337,103
P50 · FY2008 · CA · contact PI
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag$321,646
P01 · FY2008 · CA · contact PI
IMaging and Tissue Correlate Core$513,861
P01 · FY2007 · CA · contact PI
Response to Fractionated radiation Therapy by MRSI$378,736
R01 · FY2007 · CA · contact PI
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag$329,219
P01 · FY2007 · CA · contact PI
Prognostic Value of Magnetic Resonance Spectroscopic Imaging (MRSI) Parameters$313,840
P50 · FY2007 · CA · contact PI
Response to Fractionated radiation Therapy by MRSI$417,545
R01 · FY2006 · CA · contact PI
Prognostic value of MRSI parameters for glioma patients$226,700
P50 · FY2006 · CA · contact PI
Response to Fractionated radiation Therapy by MRSI$412,794
R01 · FY2005 · CA
Prognostic value of MRSI parameters for glioma patients$226,424
P50 · FY2005 · CA
Tools for Improved Radiation Treatment Using MRSI$201,281
R21 · FY2005 · CA
Response to Fractionated radiation Therapy by MRSI$403,063
R01 · FY2004 · CA
Prognostic value of MRSI parameters for glioma patients$216,895
P50 · FY2004 · CA
Tools for Improved Radiation Treatment Using MRSI$198,500
R21 · FY2004 · CA
Response to Fractionated radiation Therapy by MRSI$383,271
R01 · FY2003 · CA
EVALUATION OF GLIOMAS USING MRI AND MRS$344,303
R01 · FY2003 · CA
Prognostic value of MRSI parameters for glioma patients$212,992
P50 · FY2003 · CA
EVALUATION OF GLIOMAS USING MRI AND MRS$341,177
R01 · FY2002 · CA
Prognostic value of MRSI parameters for glioma patients$199,478
P50 · FY2002 · CA
MRI/MRSI EVALUATION OF RADIOSURGERY FOR BRAIN TUMORS$114,251
R01 · FY2002 · CA
EVALUATION OF GLIOMAS USING MRI AND MRS$338,591
R01 · FY2001 · CA
MRI/MRSI EVALUATION OF RADIOSURGERY FOR BRAIN TUMORS$334,445
R01 · FY2001 · CA
EVALUATION OF GLIOMAS USING MRI AND MRS$333,751
R01 · FY2000 · CA
MRI/MRSI EVALUATION OF RADIOSURGERY FOR BRAIN TUMORS$329,327
R01 · FY2000 · CA